Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Promising Biomarker And Candidate Tumor Suppressor Gene Identified For Colorectal Cancer
Researchers have identified a new candidate tumor suppressor gene in colorectal cancer and examined its use as a potential biomarker in stool samples, according to a new study published online June 17 in the Journal of the National Cancer Institute.

TB-HIV Link Emphasised In Uganda Event
"I am stopping TB and controlling HIV" was the theme of an event marking World TB Day (24 March) in Uganda"s Masindi district. The Union Uganda Office participated in this event, which attracted representatives from both government and a wide variety of NGOs, as well as the public.
News of the day
Abdominal Massage Shown To Benefit Constipation In MS
Trail results have highlighted the benefit of abdominal massage in the management of constipation - a common symptom in people with multiple sclerosis (MS).
Diagnostics

Merck Seeks European License For Cladribine for relapsing remitting MS

Merck Serono announced that it is seeking a European license for cladribine, its oral therapy that is in late-stage clinical trials for relapsing remitting MS. The announcement comes after results of a phase III clinical trial were reported in April at the annual American Academy of Neurology meeting in Seattle Washington. If the application meets all of the regulatory hurdles, it is set to be the first oral disease modifying drug available to people with MS. If no delays are made, cladribine could be available as early as the middle of 2010, which could mean more choice for people with MS. Multiple Scleroris Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009